Pipeline Built for Life Sciences' Trust Bar
LIMS, clinical trial management, and lab-data platforms don't get bought on a cold pitch. They get bought after a lab director, a quality lead, and an IT security reviewer all sign off. We build outbound that earns that scrutiny instead of triggering it.
We Speak to Scientists, Not Around Them
Lab directors and R&D leaders can smell a generic SaaS pitch instantly, and a single hollow claim can sink a deal before IT security even reviews it. Life sciences buyers expect precision, data provenance, and evidence of compliance fluency from the first message.
Our outreach is written and reviewed to hold up under that scrutiny — grounded in validation, 21 CFR Part 11 and HIPAA-adjacent concerns, and real lab workflows — so your first conversation starts from credibility instead of having to earn it back.
Three Ways We Build Your Pipeline
Scientific Account-Based Outreach
Messaging written with real domain fluency for lab directors, principal investigators, and R&D leaders — grounded in workflow specifics, not generic software benefits.
Compliance-Fluent Positioning
We frame your outreach around the validation, data-integrity, and security questions your buyers already have, so IT and quality reviewers see credibility before they see a demo.
CRO & Pharma Account Mapping
Account-based programs targeting CROs, biotech startups, and pharma R&D divisions, sequenced around funding events, trial phases, and conference calendars like SLAS and BIO.